NEW YORK, July 25 - In line with a recent warning that sales of GeneChip products and do-it-yourself arraying equipment has slowed, Affymetrix reported revenues of $49.5 million for the second quarter Wednesday, compared to $45.4 million in the same period last year.  

These revenues comprised a total nine percent increase over the year-ago quarter, and landed at the high end of the company's revised revenue outlook of between $44 to $50 million. The company issued these figures in June, cutting back on initial revenue projection of between $56 and $58 million.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.